Status:
UNKNOWN
A Prospective Cohort Study of Compound Nanxing Zhitong Ointment
Lead Sponsor:
Jiangsu Kanion Pharmaceutical Co., Ltd
Conditions:
Chronic Musculoskeletal Pain
Eligibility:
All Genders
Brief Summary
The purpose of this study is to evaluate the safety and the efficacy of compound Nanxing pain relief cream in the treatment of chronic pain in the musculoskeletal system
Detailed Description
Chronic pain, especially in the musculoskeletal system, is prevalent worldwide. Many studies show the burdens they impose: pain, disability, reduced quality of life (QoL), marked impairment of partici...
Eligibility Criteria
Inclusion
- Attendance at orthopedic, rheumatology and pain clinics for.
Exclusion
- Indication for surgery.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05201365
Start Date
January 1 2022
End Date
January 1 2024
Last Update
January 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.